Showing results (251-260 of 1,278) with videos related to

Sort By:
Pageof 128
PET Clinics|June 21, 2016
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET ImagingEmily C Ayers, Sara Fardin, Saeid Gholami, et al.
PET Clinics|November 8, 2020
Assessment of Total-Body Atherosclerosis by PET/Computed TomographyPoul Flemming Høilund-Carlsen, Reza Piri, Oke Gerke, et al.
Nuclear Medicine Communications|April 9, 2016
18F-FDG uptake and clearance in patients with compromised renal functionScott R Akers, Thomas J Werner, Domenico Rubello, et al.
AJR. American Journal of Roentgenology|May 23, 2018
Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic ImagingAli Gholamrezanezhad, Kyle Basques, Ali Batouli, et al.
Japanese Journal of Radiology|November 28, 2009
Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CTFrancesco Bertagna, Giorgio Biasiotto, Carlo Rodella, et al.
Hellenic Journal of Nuclear Medicine|July 12, 2017
Can semiquantitative measurements of SUVmax and cut-off values differentiate colorectal malignant from benign lessions?Tram Nguyen, Søren Hess, Henrik Petersen, et al.
Clinical Nuclear Medicine|June 14, 2023
FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer DiseasePoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Abass Alavi, et al.
PET Clinics|May 10, 2016
FDG PET Assessment of Osteomyelitis: A ReviewPhyllis Dioguardi, Santosh R Gaddam, Hongming Zhuang, et al.
Clinical Nuclear Medicine|February 20, 2003
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablationGregory S Anderson, Frank Brinkmann, Michael C Soulen, et al.
Clinical Nuclear Medicine|August 5, 2003
Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancerNasrin V Ghesani, Xinhui Sun, Hongming Zhuang, et al.
Pageof 128